HealthEquity (HQY) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
HealthEquity (HQY) quarterly earnings & revenue
HealthEquity (HQY) reported revenue of $354.64M for Q1 2027, up 7.2% year-over-year, with net income of $69.42M and diluted EPS of $0.82.
Over the last four reported quarters, HealthEquity generated $1.34B in revenue and $230.70M in net income.
HealthEquity's next earnings report is scheduled for September 1, 2026 after market close; analysts estimate EPS of $1.19.
HealthEquity quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q1 2027 | $354.64M | +7.2% | $69.42M | $0.82 |
| Q4 2026 | $334.59M | +7.3% | $49.74M | $0.58 |
| Q3 2026 | $322.16M | +7.2% | $51.69M | $0.59 |
| Q2 2026 | $325.83M | +8.6% | $59.85M | $0.68 |
| Q1 2026 | $330.84M | +15.0% | $53.91M | $0.61 |
| Q4 2025 | $311.82M | +18.8% | $26.36M | $0.30 |
| Q3 2025 | $300.43M | +20.5% | $5.70M | $0.06 |
| Q2 2025 | $299.93M | +23.1% | $35.82M | $0.40 |
HealthEquity (HQY) — frequently asked questions
When does HealthEquity (HQY) report earnings next?
HealthEquity is expected to report earnings on September 1, 2026 after market close. Analysts estimate EPS of $1.19.
What was HQY's revenue last quarter?
HealthEquity reported revenue of $354.64M in Q1 2027, up 7.2% from the same quarter a year earlier.
What was HQY's EPS last quarter?
HealthEquity reported diluted EPS of $0.82 in Q1 2027.
Is HealthEquity profitable?
HealthEquity is currently profitable, with $230.70M in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)